In light of the need to act quickly and efficiently to respond to the COVID-19 public health emergency, the US Food and Drug Administration (FDA) on Friday said that it anticipates that prior public participation will not be feasible or appropriate before FDA implements COVID-19-related guidance documents.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,